Nuzenio

Tipranks Alterity Therapeutics

Tipranks Alterity Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 08:22:55 GMTAlterity Therapeutics Expands Equity Base With New ASX Share Quotation - TipRanks
Thu, 06 Aug 2026 07:20:58 GMTAlterity Therapeutics to Highlight MSA Program at Canaccord Growth Conference - TipRanks
Tue, 04 Aug 2026 10:51:34 GMTAlterity Therapeutics Files August 3 Application to Quote ATH Securities - TipRanks
Tue, 04 Aug 2026 06:58:00 GMTAlterity Therapeutics Adds 81,838 New Shares to ASX Listing - The Globe and Mail
Thu, 30 Jul 2026 07:00:00 GMTAlterity Therapeutics Secures FDA Pathway and Bolsters Funding for ATH434 Phase 3 in MSA - TipRanks
Thu, 30 Jul 2026 01:08:06 GMTAlterity Wins FDA Backing for ATH434 Phase 3 Pathway in Multiple System Atrophy - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Alterity Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.